SYNTHESIS OF GLYCIVIR DERIVATIVES USING MODIFICATION OF SYNTHESIS PROCEDURE STUDYING THEIR ANTIVIRAL ACTIVITY AGAINST ENV-PSEUDOVIROUSES HIV-1

UDC 578.233.33+578.233.36

  • Anastasiya Alekseevna Fando FBUN SSC VB “Vector” of Rospotrebnadzor Email: nastyafando@gmail.com
  • Vladislav Viktorovich Fomenko Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS Email: fomenko@nioch.nsc.ru
  • Nadezhda Borisovna Rudometova FBUN SSC VB “Vector” of Rospotrebnadzor Email: andreeva_nb@vector.nsc.ru
  • Nina Ivanovna Komarova Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS Email: komar@nioch.nsc.ru
  • Larisa Ivanovna Karpenko FBUN SSC VB “Vector” of Rospotrebnadzor Email: lkarpenko@ngs.ru
  • Nariman Faridovich Salakhutdinov Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS Email: anvar@nioch.nsc.ru
Keywords: glycivir, HIV-1, glycerrizinic acid trinicotinates, selectivity index, 50% inhibitory concentration

Abstract

HIV infection still remains a global health problem around the world. The fight against infection is carried out both through preventive measures and timely testing for the presence of HIV and the use of antiretroviral therapy (ART) when it is detected. Researchers are constantly actively searching for new medicinal agents. In this work, new modified methods for the synthesis of glycivir were tested, including changing the holding time of the reaction mixture, varying the amount of starting reagents, adding catalysts, replacing the solvent, and replacing the condensing agent. Ten variants of glycivir were obtained, for each of which, using the MTT test, a 50% cytotoxic concentration was determined against the TZM-bl cell line and antiviral activity on the model of HIV-1 env-pseudoviruses. Sample 10 had the greatest activity against HIV-1 env-pseudoviruses, the synthesis of which involved the complete replacement of phosphorus and pyridine pentachloride with more accessible and less toxic methyl chloroformate and triethylamine in chloroform. These changes made to the original method for the synthesis of glycivir make it possible to obtain a drug that is most similar in biological activity to glycivir, but at the same time replace highly toxic reagents during the synthesis with less toxic and cheaper ones.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Anastasiya Alekseevna Fando, FBUN SSC VB “Vector” of Rospotrebnadzor

стажер-исследователь

Vladislav Viktorovich Fomenko, Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS

кандидат химических наук, научный сотрудник

Nadezhda Borisovna Rudometova, FBUN SSC VB “Vector” of Rospotrebnadzor

кандидат биологических наук, старший научный сотрудник

Nina Ivanovna Komarova, Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS

ведущий инженер

Larisa Ivanovna Karpenko, FBUN SSC VB “Vector” of Rospotrebnadzor

доктор биологических наук, доцент, ведущий научный сотрудник, заведующая лабораторией рекомбинантных вакцин

Nariman Faridovich Salakhutdinov, Novosibirsk Institute of Organic Chemistry named after. N.N. Vorozhtsov SB RAS

доктор химических наук, чл.-корр. РАН, заведующий лабораторией

References

Tompa D.R., Immanuel A., Srikanth S., Kadhirvel S. International journal of biological macromolecules, 2021, vol. 172, pp. 524–541. DOI: 10.1016/j.ijbiomac.2021.01.076.

Phanuphak N., Gulick R.M. Current Opinion in HIV and AIDS, 2020, vol. 15, pp. 4–12. DOI: 10.1097/COH.0000000000000588.

Arts E.J., Hazuda D.J. Cold Spring Harbor perspectives in medicine, 2012, vol. 2(4), a007161. DOI: 10.1101/cshperspect.a007161.

Yarovaya O.I., Salakhutdinov N.F. Russian Chemical Reviews, 2021, vol. 90, p. 488. DOI: 10.1070/RCR4969.

Musarra-Pizzo M., Pennisi R., Ben-Amor I., Mandalari G., Sciortino M.T. Viruses, 2021, vol. 13, p. 828. DOI: 10.3390/v13050828.

Hirabayashi K., Iwata S., Matsumoto H., Mori T., Shibata S., Baba M., Ito M., Shigeta S., Nakashima H., Yamamo-to N. Chemical and pharmaceutical bulletin, 1991, vol. 39, pp. 112–115. DOI: 10.1248/cpb.39.112.

Ji B., Zhao Y., Yu P., Yang B., Zhou C., Yu Z. Talanta, 2018, vol. 190, pp. 450–459. DOI: 10.1016/j.talanta.2018.08.020.

Sokolova A.S., Putilova V.P., Yarovaya O.I., Zybkina A.V., Mordvinova E.D., Zaykovskaya A.V., Shcherba-kov D.N., Orshanskaya I.R., Sinegubova E.O.,. Esaulkova I.L, Borisevich S.S., Bormotov N.I., Shishkina L.N., Za-rubaev V.V., Pyankov O.V. Molecules, 2021, vol. 26, p. 2235. DOI: 10.3390/molecules26082235.

Rex R.S., Nadar M.S., Selvakumar P.M. BiorgOrgChem, 2018, vol. 2, pp. 61–70. DOI: 10.15406/mojboc.2018.02.00058.

Ghildiyal R., Prakash V., Chaudhary V.K., Gupta V., Gabrani R. Plant-derived Bioactives. Springer, Singapore, 2020, pp. 279–295. DOI: 10.1007/978-981-15-1761-7_12.

Baltina L.A., Kondratenko R.M., Baltina (ml) L.A., Plyasunova O.A., Pokrovskiy A.G., Tolstikov G.A. Khimiko-farmatsevticheskiy zhurnal, 2009, vol. 43, no. 10, pp. 3–12. DOI: 10.30906/0023-1134-2009-43-10-3-12. (in Russ.).

Ito M., SatoA., Hirabayashi K., Tanabe F., Shigeta S., Baba M., Clercq E.D., Nakashima H., Yamamoto N. Antiviral Research, 1988, vol. 10, pp. 289–298. DOI: 10.1016/0166-3542(88)90047-2.

Zarubayev V.V., Anikin V.B., Smirnov V.S. Infektsiya i immunitet, 2016, vol. 6, no. 3, pp. 199–206. (in Russ.).

Kondratenko P.M., Baltina L.A., Mustafina SR., Vasil'yeva Ye.V., Pompei R., Deydda D., Plyasunova O.A., Po-krovskiy A.G., Tolstikov G.A. Bioorganicheskaya khimiya, 2004, vol. 30, no. 3, pp. 308–315. (in Russ.).

Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L. (Jr.), Tolstikov G.A., Doerr H.W., Cinatl J. (jr.). J. Med. Chem., 2005, vol. 48, pp. 1256–1259. DOI: 10.1021/jm0493008.

Patent 2299740 (RU). 2007. (in Russ.).

Patent 2199547 (RU). 2003. (in Russ.).

Patent 2304145 (RU). 2007. (in Russ.).

Fomenko V.V., Rudometova N.B., Yarovaya O.I., Rogachev A.D., Fando A.A., Zaykovskaya A.V., Komarova N.I., Shcherbakov D.N., Pyankov O.V., Pokrovsky A.G., Karpenko L.I., Maksyutov R.A., Salakhutdinov N.F. Molecules, 2022, vol. 27, p. 295. DOI: 10.3390/molecules27010295.

Kovaleva K.S., Yarovaya O.I., Gatilov Yu.V., Slita A.V., Yesaulkova Ya.L., Zarubayev V.V., Rudometova N.B., Shcherbakova N.S., Shcherbakov D.N., Salakhutdinov N.F. Khimiya geterotsiklicheskikh soyedineniy, 2021, vol. 57, no. 4, pp. 455–461. (in Russ.).

Revilla A., Delgado E., Christian E.C., Dalrymple J., Vega Y., Carrera C., González-Galeano M., Ocampo A., de Cas-tro R.O., Lezaún M.J., Rodríguez R., Mariño A., Ordóñez P., Cilla G., Cisterna R., Santamaría J.M., Prieto S., Rakh-manova A., Vinogradova A., Ríos M., Pérez-Álvarez L., Nájera R., Montefiori D.C., Seaman M.S., Thomson M.M. AIDS Res. Hum. Retroviruses, 2011, vol. 27, pp. 889–901. DOI: 10.1089/aid.2010.0177.

Domingo P., de Benito N. EBioMedicine, 2021, vol. 74, 103703. DOI: 10.1016/j.ebiom.2021.103703.

Legnani L., Colombo D., Venuti A., Pastori C., Lopalco L., Toma L., Mori M., Grazioso G., Villa S. Med. Chem. Commun., 2017, vol. 8, pp. 422–433. DOI: 10.1039/C6MD00575F.

Baram G.I., Grachev M.A., Komarova N.I., Perelroyzen M.P., Bolvanov Yu. A., Kuzmin S.V., Kargaltsev V.V., Kuper E.A. Journal of Chromatography A, 1983, vol. 264, pp. 69–90. DOI: 10.1016/S0021-9673(01)95007-1.

Ladinsky M.S., Gnanapragasam P.N., Yang Z., West A.P., Kay M.S., Bjorkman P.J. Elife, 2020, vol. 9, e58411. DOI: 10.7554/eLife.58411.

Zaitsev B.N., Taranov O.S., Rudometova N.B., Shcherbakova N.S., Ilyichev A.A., Karpenko L.I. Vavilov Journal of Genetics and Breeding, 2019, vol. 23, pp. 337–342. DOI: 10.18699/VJ19.498.

Dando T.M., Perry C.M. Drugs, 2003, vol. 63, pp. 2755–2766. DOI: 10.2165/00003495-200363240-00005.

Lalezari J.P., Henry K., O'Hearn M., Montaner J.S.G., Piliero P.J.,Trottier B., Walmsley S., Cohen C., Kuritzkes D.R., Eron J.J. Jr., Chung J., DeMasi R., Donatacci L., Drobnes C., Delehanty J., Salgo M. New England Journal of Medi-cine, 2003, vol. 348, pp. 2175–2185. DOI: 10.1056/NEJMoa035026.

Kitchen C.M.R., Nuño M., Kitchen S.G., Krogstad P. Therapeutics and clinical risk management, 2008, vol. 4, pp. 433–439. DOI: 10.2147/tcrm.s1962.

Clercq E.D. International Journal of Antimicrobial Agents, 2009, vol. 33, pp. 307–320. DOI: 10.1016/j.ijantimicag.2008.10.010.

Published
2023-12-15
How to Cite
1. Fando A. A., Fomenko V. V., Rudometova N. B., Komarova N. I., Karpenko L. I., Salakhutdinov N. F. SYNTHESIS OF GLYCIVIR DERIVATIVES USING MODIFICATION OF SYNTHESIS PROCEDURE STUDYING THEIR ANTIVIRAL ACTIVITY AGAINST ENV-PSEUDOVIROUSES HIV-1 // chemistry of plant raw material, 2023. № 4. P. 387-395. URL: http://journal.asu.ru/cw/article/view/13841.
Section
Low-molecular weight compounds